BKV Corp (BKV) officer adds shares through Employee Stock Purchase Plan
Rhea-AI Filing Summary
BKV Corp officer and Chief Corporate Development Officer acquired company stock through an employee stock purchase plan. On 01/02/2026, the reporting person bought 97 shares of BKV Corp common stock at a price of $18.8785 per share under the BKV Corporation Employee Stock Purchase Plan. After this transaction, the officer beneficially owned 112,772 shares of BKV Corp common stock in direct ownership. The filing notes that this purchase was made under the ESPP at a 15% discount to the lower of the stock’s closing price on July 1, 2025 or December 31, 2025, and that the transaction is being voluntarily reported as exempt under Rule 16b-3(d) and Rule 16b-3(c).
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 97 | $18.8785 | $2K |
Footnotes (1)
- The shares were acquired under the BKV Corporation Employee Stock Purchase Plan ("ESPP") in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c). The reporting person is voluntarily reporting this transaction. In accordance with the ESPP, these shares were purchased at a price equal to 85% of the lesser of (i) closing price of the Issuer's common stock on the first trading day of the offering period, July 1, 2025, or (ii) closing price of the Issuer's common stock on the last trading day of the offering period, December 31, 2025.
FAQ
What insider transaction did BKV (BKV) report in this Form 4?
BKV reported that its Chief Corporate Development Officer acquired 97 shares of BKV Corp common stock on 01/02/2026 through the company’s Employee Stock Purchase Plan.
What role does the reporting person hold at BKV Corp?
The reporting person is an officer of BKV Corp, serving as the company’s Chief Corporate Development Officer.
How was the purchase price determined under BKV Corp’s Employee Stock Purchase Plan?
Under the ESPP, the shares were bought at 85% of the lesser of the closing price on July 1, 2025 (the first trading day of the offering period) or on December 31, 2025 (the last trading day of the offering period).
Was this BKV insider purchase exempt under SEC rules?
Yes. The filing states the shares were acquired under the ESPP in a transaction exempt under Rule 16b-3(d) and Rule 16b-3(c), and that the reporting person is voluntarily reporting the transaction.